Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Tocris Bioscience™ ESI 09

Click to view available options
Quantity:
10 mg
50 mg
Description
ESI 09 is an EPAC inhibitor. Inhibits EPAC-mediated insulin release from pancreatic β cells. Selective for EPAC over PKA. ESI 09 decreases migration and invasion of AsPc-1 and PANC-1 pancreatic cancer cells in vitro.
Specifications
Specifications
Chemical Name or Material | EPAC Inhibitors |
CAS | 263707-16-0 |
Synonym | α-[(2-(3-Chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-β-oxo-3-isoxazolepropanenitrile |
Quantity | 50 mg |
Solubility | Soluble to 100mM in DMSO and to 20mM in ethanol |
Molecular Formula | C16H15ClN4O2 |
Formula Weight | 330.77 |
Physical Form | Solid |
Product Type | Bioactive Small Molecule |
Purity | >98% |
Research Use Only. Not For Human or Veterinary Use
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction